BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38271272)

  • 1. Lymph node examination and survival in resected pancreatic ductal adenocarcinoma: retrospective study.
    Goess R; Jäger C; Perinel J; Pergolini I; Demir E; Safak O; Scheufele F; Schorn S; Muckenhuber A; Adham M; Novotny A; Ceyhan GO; Friess H; Demir IE
    BJS Open; 2024 Jan; 8(1):. PubMed ID: 38271272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of lymph node status in patients after total pancreatectomy for pancreatic ductal adenocarcinoma: A strobe-compliant study.
    Zheng ZJ; Wang MJ; Tan CL; Chen YH; Ping J; Liu XB
    Medicine (Baltimore); 2020 Feb; 99(8):e19327. PubMed ID: 32080152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Number of Examined Lymph Nodes and Nodal Status Assessment in Distal Pancreatectomy for Body/Tail Ductal Adenocarcinoma.
    Malleo G; Maggino L; Ferrone CR; Marchegiani G; Mino-Kenudson M; Capelli P; Rusev B; Lillemoe KD; Bassi C; Fernàndez-Del Castillo C; Salvia R
    Ann Surg; 2019 Dec; 270(6):1138-1146. PubMed ID: 29672406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Criterion for Lymph Nodes Dissection in Distal Pancreatectomy for Ductal Adenocarcinoma: A Population Study of the US SEER Database.
    Wang W; Shen Z; Zhang J; Chen H; Deng X; Peng C; Xie J; Xu Z; Shen B
    Ann Surg Oncol; 2022 Mar; 29(3):1533-1539. PubMed ID: 34622372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma.
    Malleo G; Maggino L; Qadan M; Marchegiani G; Ferrone CR; Paiella S; Luchini C; Mino-Kenudson M; Capelli P; Scarpa A; Lillemoe KD; Bassi C; Castillo CF; Salvia R
    Ann Surg; 2022 Nov; 276(5):e518-e526. PubMed ID: 33177357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comprehensive Assessment of Accurate Lymph Node Staging and Preoperative Detection in Resected Pancreatic Cancer.
    Masuda T; Dann AM; Elliott IA; Baba H; Kim S; Sedarat A; Muthusamy VR; Girgis MD; Joe Hines O; Reber HA; Donahue TR
    J Gastrointest Surg; 2018 Feb; 22(2):295-302. PubMed ID: 29043580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reappraisal of nodal staging and study of lymph node station involvement in distal pancreatectomy for body-tail pancreatic ductal adenocarcinoma.
    Malleo G; Maggino L; Nobile S; Casciani F; Cacciatori N; Paiella S; Luchini C; Rusev B; Capelli P; Marchegiani G; Bassi C; Salvia R
    Eur J Surg Oncol; 2020 Sep; 46(9):1734-1741. PubMed ID: 32327367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Greater lymph node retrieval and lymph node ratio impacts survival in resected pancreatic cancer.
    Mirkin KA; Hollenbeak CS; Wong J
    J Surg Res; 2017 Dec; 220():12-24. PubMed ID: 29180173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N0/N1, PNL, or LNR? The effect of lymph node number on accurate survival prediction in pancreatic ductal adenocarcinoma.
    Valsangkar NP; Bush DM; Michaelson JS; Ferrone CR; Wargo JA; Lillemoe KD; Fernández-del Castillo C; Warshaw AL; Thayer SP
    J Gastrointest Surg; 2013 Feb; 17(2):257-66. PubMed ID: 23229885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of Examined Lymph Node Number in Accurate Staging and Long-term Survival in Resected Stage I-II Pancreatic Cancer-More is Better? A Large International Population-based Cohort Study.
    Huang L; Jansen L; Balavarca Y; van der Geest L; Lemmens V; Koerkamp BG; van Santvoort HC; Grützmann R; Besselink MG; Schrotz-King P; Brenner H
    Ann Surg; 2021 Dec; 274(6):e554-e563. PubMed ID: 31425290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining a minimum number of examined lymph nodes improves the prognostic value of lymphadenectomy in pancreas ductal adenocarcinoma.
    Pu N; Gao S; Beckman R; Ding D; Wright M; Chen Z; Zhu Y; Hu H; Yin L; Beckman M; Thompson E; Hruban RH; Cameron JL; Gage MM; Lafaro KJ; Burns WR; Wolfgang CL; He J; Yu J; Burkhart RA
    HPB (Oxford); 2021 Apr; 23(4):575-586. PubMed ID: 32900612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of para-aortic lymph node status in resected pancreatic ductal adenocarcinoma and invasive intraductal papillary mucinous neoplasm - Time to consider a reclassification?
    Linder S; Holmberg M; Engstrand J; Ghorbani P; Sparrelid E
    Surg Oncol; 2022 May; 41():101735. PubMed ID: 35287096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph Node Metastatic Patterns and Survival Predictors Based on Tumor Size in Pancreatic Ductal Adenocarcinoma.
    Pu N; Chen Q; Gan W; Shen Y; Gao S; Habib JR; Yin H; Zhang J; Kinny-Köster B; Cui M; Li J; Dong Y; Nagai M; Liu L; Yu J; Wu W; Lou W
    Adv Ther; 2021 Aug; 38(8):4258-4270. PubMed ID: 34176089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.
    Robinson SM; Rahman A; Haugk B; French JJ; Manas DM; Jaques BC; Charnley RM; White SA
    Eur J Surg Oncol; 2012 Apr; 38(4):333-9. PubMed ID: 22317758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.
    Slidell MB; Chang DC; Cameron JL; Wolfgang C; Herman JM; Schulick RD; Choti MA; Pawlik TM
    Ann Surg Oncol; 2008 Jan; 15(1):165-74. PubMed ID: 17896141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accurate Nodal Staging in Pancreatic Cancer in the Era of Neoadjuvant Therapy.
    Javed AA; Ding D; Baig E; Wright MJ; Teinor JA; Mansoor D; Thompson E; Hruban RH; Narang A; Burns WR; Burkhart RA; Lafaro K; Weiss MJ; Cameron JL; Wolfgang CL; He J
    World J Surg; 2022 Mar; 46(3):667-677. PubMed ID: 34994834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the mechanism of lymph node invasion affect survival in patients with pancreatic ductal adenocarcinoma?
    Konstantinidis IT; Deshpande V; Zheng H; Wargo JA; Fernandez-del Castillo C; Thayer SP; Androutsopoulos V; Lauwers GY; Warshaw AL; Ferrone CR
    J Gastrointest Surg; 2010 Feb; 14(2):261-7. PubMed ID: 19937477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved long-term outcomes after resection of pancreatic adenocarcinoma: a comparison between two time periods.
    Serrano PE; Cleary SP; Dhani N; Kim PT; Greig PD; Leung K; Moulton CA; Gallinger S; Wei AC
    Ann Surg Oncol; 2015 Apr; 22(4):1160-7. PubMed ID: 25348784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis.
    La Torre M; Cavallini M; Ramacciato G; Cosenza G; Rossi Del Monte S; Nigri G; Ferri M; Mercantini P; Ziparo V
    J Surg Oncol; 2011 Nov; 104(6):629-33. PubMed ID: 21713779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.
    Pai RK; Beck AH; Mitchem J; Linehan DC; Chang DT; Norton JA; Pai RK
    Am J Surg Pathol; 2011 Feb; 35(2):228-34. PubMed ID: 21263243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.